The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Open accessAbstract
Most normal mammalian cells have a finite lifespan, thought to constitute a protective mechanism against unlimited proliferation. This phenomenon, called senescence, is driven by telomere attrition, which triggers the induction of tumour suppressors including p16(INK4a) (ref. 5). In cultured cells, senescence can be elicited prematurely by oncogenes; however, whether such oncogene-induced senescence represents a physiological process has long been debated. Human naevi (moles) are benign tumours of melanocytes that frequently harbour oncogenic mutations (predominantly V600E, where valine is substituted for glutamic acid) in BRAF, a protein kinase and downstream effector of Ras. Nonetheless, naevi typically remain in a growth-arrested state for decades and only rarely progress into malignancy (melanoma). This raises the question of whether naevi undergo BRAF(V600E)-induced senescence. Here we show that sustained BRAF(V600E) expression in human melanocytes induces cell cycle arrest, which is accompanied by the induction of both p16(INK4a) and senescence-associated acidic beta-galactosidase (SA-beta-Gal) activity, a commonly used senescence marker. Validating these results in vivo, congenital naevi are invariably positive for SA-beta-Gal, demonstrating the presence of this classical senescence-associated marker in a largely growth-arrested, neoplastic human lesion. In growth-arrested melanocytes, both in vitro and in situ, we observed a marked mosaic induction of p16(INK4a), suggesting that factors other than p16(INK4a) contribute to protection against BRAF(V600E)-driven proliferation. Naevi do not appear to suffer from telomere attrition, arguing in favour of an active oncogene-driven senescence process, rather than a loss of replicative potential. Thus, both in vitro and in vivo, BRAF(V600E)-expressing melanocytes display classical hallmarks of senescence, suggesting that oncogene-induced senescence represents a genuine protective physiological process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lastly, in mice and humans, a senescence response to strong mitogenic signals, such as those delivered by certain oncogenes, prevents premalignant lesions from progressing to malignant cancers [ 16 – 19 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, the BRAF oncogenic mutation found in more than half of all malignant cutaneous melanomas is commonly found also in non-malignant nevi, where it causes oncogene-induced senescence exemplified by high levels of CDKN2A and SA-β-gal expression225–227.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [225]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mouse models of melanoma and human nevi (both oncogene driven) show accumulation of SA-β-gal+–CDKN2A+ foci224,225.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [225]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This type of oncogene-induced senescence (OIS) is frequently observed in premalignant and benign tumour tissues [37 -39] but not in advanced malignant tumours, where cancer cells have already bypassed senescence.”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [37]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Hallmarks of senescent cells were subsequently identified in dermal premalignant lesions, specifically human melanocytic naevi 81,82 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [81]
The cited source says what the claim attributes to it.
In the citing paper
“Studies in various mouse models, supported by correlative evidence from human- derived tissue samples, have underscored the tumour- suppressive role of OIS 81,120-123 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [81]
In the citing paper
“Oncogene-induced senescence protects against tumor initiation 34–37.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [35]
In the citing paper
“OIS is a powerful tumor suppressor mechanism 34–37.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [35]
In the citing paper
“in vitro experiments showed that cells that lack functional p53 or overexpress the H3K9me3 demethylase JMJD2c46,50 — which therefore cannot enter senescence in response to pro-senescent oncogenes such as Ras-G12V or Braf-V600E46,51 — also failed to enter VIS and lacked a SASP upon infection with SARS-CoV-2 (ref.28).”
From COVID-19 and cellular senescence (2023) · cites this paper as [51]
In the citing paper
“Studies have demonstrated high levels of senescence in premalignant lesions and lower levels in invasive disease, suggesting a role for senescence in blocking malignant progression [2,31,32].”
From Senescence and Cancer: A Review of Clinical Implications of Senescence and Senotherapies (2020) · cites this paper as [32]
In the citing paper
“human melanocytic naevi (an OIS model), remain non-proliferative for decades without transformation into malignant melanoma 25”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [25]
In the citing paper
“This is a seminal study that identified OIS of human melanocytic naevi.”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [25]
In the citing paper
“Senescence markers are detected in premalignant tumor lesions but not at later stages of tumor development [17,18,19].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [19]
In the citing paper
“Benign melanocytic lesions, which are melanoma precursors in humans, express high p16 and are an in vivo example of OIS [19,55].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [19]
In the citing paper
“Indeed, such telomeres are not visibly shorter than functional telomeres [114] in human melanocytic nevi with frequent BRAF mutations, a typical OIS feature in vivo [19].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [19]
In the citing paper
“Indeed, its locus is more commonly deleted or silenced than mutated in melanoma, the more malignant later stage of disease [19,55].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [19]
In the citing paper
“For example, N-RAS- or B-RAF-activating mutations are commonly found in benign melanocytic nevi that show features of senescence, such as elevated p16 levels, but that do not express appreciable levels of ARF or p53 [19,55].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [19]
In the citing paper
“In humans, Ras activation appears to induce only p16 [19,127].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [19]
In the citing paper
“senescence occurs during the formation of benign cutaneous melanocytic nevi that express an oncogenic form of BRAF [19].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [19]
In the citing paper
“Importantly, this work also provided evidence for the occurrence of 4N senescent cells in human melanocyte naevi, the first in vivo senescence model, 94 suggesting that the G2 exit program has a more general role in senescence.”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [94]
In the citing paper
“The acronym oncogene-induced senescence (OIS) was coined following the demonstration that the aberrant activation of oncogenes (e.g., Ras, BRAF V600E, and c-Myc) or loss of tumor suppressor genes (e.g., PTEN) temporarily arrests a large variety of tumors in a pre-malignant state 180-183 (Figure 3B).”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [182]
In the citing paper
“BRAFV600E mutation alone is often insufficient to drive malignant transformation of melanocytes24.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [24]
In the citing paper
“For example, developmental senescent cells express p21WAF1/Cip1 but not p16INK4a9,10, while the reverse is observed in melanocytic nevi36,37.”
From Algorithmic assessment of cellular senescence in experimental and clinical specimens (2021) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
High frequency of BRAF mutations in nevi
Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1054 · Cited by 1,730
Reversal of human cellular senescence: roles of the p53 and p16 pathways
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg417 · Cited by 1,457
Lowe, S. W., Cepero, E., & Evan, G. I. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,374
Flagged first, then by citations
Research works printed but not linked: 1
- Peeper, D. S. & Mooi, W. J. Pathogenesis of melanocytic naevi: growth arrest linked with cellular senescence? Histopathology 41, S139–S143 (2002)
Cited by
Sorted by citations
Items 701–800 of 1,009
Gadd45a Functions as a Promoter or Suppressor of Breast Cancer Dependent on the Oncogenic Stress
Tront, J. S., Huang, Y., Fornace, A. J., Hoffman‐Liebermann, B., & Liebermann, D. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2177 · Cited by 64
Cellular senescence bypass screen identifies new putative tumor suppressor genes
Martínez-Leal, J. F., Fominaya, J. M., Cascón, A., Guijarro, M. V., Blanco‐Aparicio, C., LLeonart, M. E., Castro, M. E., y Cajal, S. R., Robledo, M., Beach, D., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210846 · Cited by 64
Inoue-Narita, T., Hamada, K., Sasaki, T., Hatakeyama, S., Fujita, S., Kawahara, K., Sasaki, M., Kishimoto, H., Eguchi, S., Kojima, I., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0889 · Cited by 64
Lv, Y., Wu, L., Jian, H., Zhang, C., Lou, Y., Kang, Y., Hou, M., Li, Z., Li, X., Sun, B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.997765 · Cited by 63
ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework
Timofeev, O. N., Giron, P., Lawo, S., Pichler, M., & Noeparast, A. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00554-5 · Cited by 63
Cellular senescence: mechanisms and relevance to cancer and aging
Yamauchi, S., & Takahashi, A. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae079 · Cited by 63
Targeting Oncogenic BRAF in Human Cancer
Pratilas, C. A., Xing, F., & Solit, D. B. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2011_162 · Cited by 63
Vemurafenib: a new treatment for BRAF-V600 mutated advanced melanoma
Larkin, J., & Fisher (2012) · Cancer Management and Research · doi:10.2147/cmar.s25284 · Cited by 63
B-Raf mutation: A key player in molecular biology of cancer
Rahman, M. A., Salajegheh, A., Smith, R. A., & Lam, A. K.-Y. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.10.005 · Cited by 63
Oncogenic BRAF-Mediated Melanoma Cell Invasion
Lu, H., Liu, S., Zhang, G., Kwong, L. N., Zhu, Y., Miller, J. P., Hu, Y., Zhong, W., Zeng, J., Wu, L. W., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.073 · Cited by 63
Relieving ferroptosis may partially reverse neurodegeneration of the auditory cortex
Chen, X., Li, D., Sun, H., Wang, W., Wu, H., Kong, W., & Kong, W. (2020) · FEBS Journal · doi:10.1111/febs.15266 · Cited by 63
Epigenetic silencing of 14-3-3sigma in cancer
Lodygin, D., & Hermeking, H. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.03.008 · Cited by 63
Nowicki, T. S., Zhao, H. L., Darżynkiewicz, Z., Moscatello, A. L., Shin, E. D., Schantz, S., Tiwari, R. K., & Geliebter, J. (2011) · Cell Cycle · doi:10.4161/cc.10.1.14362 · Cited by 63
Identification of direct transcriptional targets of V600EBRAF/MEK signalling in melanoma
Packer, L., East, P., Reis-Filho, J. S., & Marais, R. (2009) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2009.00618.x · Cited by 62
IGFBP7 Is Not Required for B-RAF-Induced Melanocyte Senescence
Scurr, L. L., Pupo, G. M., Becker, T. M., Lai, K., Schrama, D., Haferkamp, S., Irvine, M., Scolyer, R. A., Mann, G. J., Becker, J. C., et al. (2010) · Cell · doi:10.1016/j.cell.2010.04.021 · Cited by 62
Latini, F. R., Hemerly, J. P., Oler, G., Riggins, G. J., & Cerutti, J. M. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0079 · Cited by 62
Regulation of Senescence in Cancer and Aging
Kong, Y., Cui, H., Ramkumar, C., & Zhang, H. (2011) · Journal of Aging Research · doi:10.4061/2011/963172 · Cited by 61
The therapeutic landscape of hepatocellular carcinoma
Gallage, S., Beccaria, M. G., Szydlowska, M., Rahbari, M., Mohr, R. U., Tacke, F., & Heikenwälder, M. F. (2021) · Med · doi:10.1016/j.medj.2021.03.002 · Cited by 61
Regulation of self‐renewal in normal and cancer stem cells
Falzacappa, M. V. V., Ronchini, C., Reavie, L. B., & Pelicci, P. G. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08727.x · Cited by 61
Oral melanocytic nevi: a clinicopathologic study of 100 cases
Ferreira, L., Jham, B. C., Assi, R., Readinger, A., & Kessler, H. P. (2015) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2015.05.008 · Cited by 61
Absence of Distinguishing Senescence Traits in Human Melanocytic Nevi
Tran, S. L., Haferkamp, S., Scurr, L. L., Gowrishankar, K., Becker, T. M., Desilva, C., Thompson, J. F., Scolyer, R. A., Kefford, R. F., & Rizos, H. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.126 · Cited by 61
PIM1 induces cellular senescence through phosphorylation of UHRF1 at Ser311
Yang, J. H., Liu, K., Yang, J. H., Jin, B., Chen, H., Zhan, X., Li, Z., Wang, L., Shen, X., Li, M., et al. (2017) · Oncogene · doi:10.1038/onc.2017.96 · Cited by 61
Cozzi, S., Parsons, P. G., Ogbourne, S. M., Pedley, J., & Boyle, G. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0348 · Cited by 61
p16INK4a modulates p53 in primary human mammary epithelial cells.
Zhang, J., Pickering, C. R., Holst, C. R., Gauthier, M. L., & Tlsty, T. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1594 · Cited by 60
Havel, J. J., Li, Z., Cheng, D., Peng, J., & Fu, H. (2014) · Oncogene · doi:10.1038/onc.2014.91 · Cited by 60
Corpet, A., & Stucki, M. (2014) · Chromosoma · doi:10.1007/s00412-014-0469-6 · Cited by 60
Reddy, J. P., Peddibhotla, S., Bu, W., Zhao, J., Haricharan, S., Du, Y. N., Podsypanina, K., Rosen, J. M., Donehower, L. A., & Li, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910665107 · Cited by 60
ING1a expression increases during replicative senescence and induces a senescent phenotype
Soliman, M. A., Berardi, P., Pastyryeva, S., Bonnefin, P., Feng, X., Colina, A. R., Young, D., & Riabowol, K. T. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00427.x · Cited by 60
Genetics and genomics of melanoma
Ghosh, P., & Chin, L. (2009) · Expert Review of Dermatology · doi:10.1586/edm.09.2 · Cited by 60
Friedman, R. J., Farber, M. J., Warycha, M. A., Papathasis, N., Miller, M. K., & Heilman, E. R. (2008) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2008.09.008 · Cited by 60
Androgen receptor levels are upregulated by Akt in prostate cancer
Ha, S., Ruoff, R., Kahoud, N., Franke, T. F., & Logan, S. K. (2011) · Endocrine Related Cancer · doi:10.1530/erc-10-0204 · Cited by 60
Nek4 Regulates Entry into Replicative Senescence and the Response to DNA Damage in Human Fibroblasts
Nguyen, C. L., Possemato, R., Bauerlein, E. L., Xie, A., Scully, R., & Hahn, W. C. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00436-12 · Cited by 61
Zou, M., Baitei, E. Y., Al‐Rijjal, R. A., Parhar, R. S., Al-Mohanna, F. A., Kimura, S., Pritchard, C. A., BinEssa, H. A., Alzahrani, A. S., Al‐Khalaf, H. H., et al. (2015) · Oncogene · doi:10.1038/onc.2015.253 · Cited by 60
TGFβ2-induced senescence during early inner ear development
Gibaja, A., Aburto, M. R., Pulido, S., Collado, M., Hurlé, J. M., Varela‐Nieto, I., & Magariños, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-42040-0 · Cited by 60
Senescence under appraisal: hopes and challenges revisited
Davan-Wetton, C. S. A., Pessolano, E., Perretti, M., & Montero‐Melendez, T. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03746-x · Cited by 61
Immune Surveillance of Unhealthy Cells by Natural Killer CellsPreprint
Iannello, A., & Raulet, D. H. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020255 · Cited by 60
Carbonneau, C. L., Despars, G., Rojas-Sutterlin, S., Fortin, A., Le, O., Hoang, T., & Beauséjour, C. M. (2012) · Blood · doi:10.1182/blood-2011-06-361626 · Cited by 59
DAMPs in immunosenescence and cancer
Chen, F., Tang, H., Cai, X., Lin, J., Kang, R., Tang, D., & Liu, J. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.09.005 · Cited by 60
Multiple facets of p53 in senescence induction and maintenance
Johmura, Y., & Nakanishi, M. (2016) · Cancer Science · doi:10.1111/cas.13060 · Cited by 59
Targeting normal and cancer senescent cells as a strategy of senotherapy
Sikora, E., Bielak-Żmijewska, A., & Mosieniak, G. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100941 · Cited by 59
Iltis, C., Moskalevska, I., Debiesse, A., Seguin, L., Fissoun, C., Cervera, L., Moudombi, L., Ardin, M., Ferrari, A., Eliott, C., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00776-z · Cited by 59
Genomic Characterization of Dysplastic Nevi Unveils Implications for Diagnosis of Melanoma
Melamed, R. D., Aydin, I. T., Rajan, G. S., Phelps, R., Silvers, D. N., Emmett, K. J., Brunner, G., Rabadan, R., & Celebi, J. T. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.11.017 · Cited by 58
Osteopontin Stimulates Preneoplastic Cellular Proliferation Through Activation of the MAPK Pathway
Luo, X., Ruhland, M. K., Pazolli, E., Lind, A. C., & Stewart, S. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0472 · Cited by 58
Lestari, B., Nakamae, I., Yoneda‐Kato, N., Morimoto, T., Kanaya, S., Yokoyama, T., Shionyu, M., Shirai, T., Meiyanto, E., & Kato, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-51244-3 · Cited by 58
Tanaka, Y., & Takahashi, A. (2020) · The Journal of Biochemistry · doi:10.1093/jb/mvaa109 · Cited by 57
Signalling by senescent melanocytes hyperactivates hair growth
Wang, X., Ramos, R., Phan, A. Q., Yamaga, K., Flesher, J. L., Jiang, S., Oh, J. W., Jin, S., Jahid, S., Kuan, C., et al. (2023) · Nature · doi:10.1038/s41586-023-06172-8 · Cited by 57
Wang, Z., Liu, Y., Takahashi, M., Hook, K. V., Kampa-Schittenhelm, K. M., Sheppard, B. C., Sears, R. C., Stork, P. A., & Lopez, C. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201514110 · Cited by 57
Immunosurveillance as a regulator of tissue homeostasis
Senovilla, L., Galluzzi, L., Zitvogel, L., & Kroemer, G. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.06.005 · Cited by 57
Therapeutic Implications of Targeting AKT Signaling in Melanoma
Madhunapantula, S. V., & Robertson, G. P. (2011) · Enzyme Research · doi:10.4061/2011/327923 · Cited by 57
NF1 loss induces senescence during human melanocyte differentiation in an iPSC ‐based model
Larribère, L., Wu, H., Novak, D., Galach, M., Bernhardt, M., Orouji, E., Weina, K., Knappe, N., Sachpekidis, C., Umansky, L., et al. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12369 · Cited by 57
Thrombospondin-1 mediates oncogenic Ras–induced senescence in premalignant lung tumors
Baek, K., Bhang, D., Zaslavsky, A., Wang, L.-C., Vachani, A., Kim, C. F., Albelda, S. Μ., Evan, G. I., & Ryeom, S. W. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67465 · Cited by 57
Fernández, I. F., Blanco, S., Lozano, J., & Lazo, P. A. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01581-09 · Cited by 57
Unlike Two Peas in a Pod: Lipid Phosphate Phosphatases and Phosphatidate Phosphatases
Kok, B. P., Venkatraman, G., Capatos, D., & Brindley, D. N. (2012) · Chemical Reviews · doi:10.1021/cr200433m · Cited by 57
Liu, G., Claret, F. X., Zhou, F., & Pan, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00135 · Cited by 57
Liver regeneration in aged mice: new insights
Pibiri, M. (2018) · Aging · doi:10.18632/aging.101524 · Cited by 57
Understanding spitzoid tumours: new insights from molecular pathology
Forno, P. D., Fletcher, A. A., Pringle, J. H., & Saldanha, G. S. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08207.x · Cited by 58
Ma, K., Xu, Q., Wang, S., Zhang, W., Liu, M., Liang, S., Zhu, H., & Xu, N. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.045 · Cited by 57
Brandhagen, B. N., Tieszen, C. R., Ulmer, T. M., Tracy, M. S., Goyeneche, A. A., & Telleria, C. M. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-35 · Cited by 56
High nevus counts confer a favorable prognosis in melanoma patients
Ribero, S., Davies, J. R., Requena, C., Carrera, C., Glass, D., Rull, R., Vidal‐Sicart, S., Vilalta, A., Alós, L., Soriano, V., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29525 · Cited by 56
Deacetylation of H4-K16Ac and heterochromatin assembly in senescence
Contrepois, K., Thuret, J., Courbeyrette, R., Fenaille, F., & Mann, C. (2012) · Epigenetics & Chromatin · doi:10.1186/1756-8935-5-15 · Cited by 56
Senescence and tumor suppression
Hinds, P. W., & Pietruska, J. R. (2017) · F1000Research · doi:10.12688/f1000research.11671.1 · Cited by 56
Stark, M. S., Tan, J. M., Tom, L. N., Jagirdar, K., Lambie, D., Schaider, H., Soyer, H. P., & Sturm, R. A. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.02.012 · Cited by 56
Elder, D. E. (2016) · Pathology · doi:10.1016/j.pathol.2015.12.002 · Cited by 56
Cellular senescence or stemness: hypoxia flips the coin
Otero-Albiol, D., & Carnero, A. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02035-0 · Cited by 56
Oncogenic transformation and experimental models of human cancer
Anna, C. S. (2007) · Frontiers in bioscience · doi:10.2741/2661 · Cited by 56
Targeting BRAF in melanoma: Biological and clinical challenges
Mandalà, M., & Voit, C. A. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.01.003 · Cited by 56
Regulation of tissue‐ and stimulus‐specific cell fate decisions by p53 in vivo
Jackson, J. G., Post, S. M., & Lozano, G. (2010) · The Journal of Pathology · doi:10.1002/path.2783 · Cited by 55
New Insights Into the Molecular Pathogenesis of Langerhans Cell Histiocytosis
Rizzo, F. M., Cives, M., Simone, V. D., & Silvestris, F. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0341 · Cited by 55
Sin3B Expression Is Required for Cellular Senescence and Is Up-regulated upon Oncogenic Stress
Grandinetti, K. B., Jelinic, P., DiMauro, T., Pellegrino, J., Rodríguez, R. F., Finnerty, P. M., Ruoff, R., Bardeesy, N. M., Logan, S. K., & David, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0537 · Cited by 55
Selt, F., Buhl, J. L., Hielscher, T., Sahm, F., Capper, D., Korshunov, A., Usta, D., Brabetz, S., Ridinger, J., Ecker, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14004 · Cited by 55
Starkebaum, G. A., & Hendrie, P. C. (2020) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2020.101510 · Cited by 55
Yang, D., Liu, L., & Zheng, X. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2008.02.001 · Cited by 55
Glucose metabolism and hexosamine pathway regulate oncogene-induced senescence
Gitenay, D., Wiel, C., Lallet-Daher, H., Vindrieux, D., Aubert, S., Payen, L. F., Simonnet, H., & Bernard, D. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.63 · Cited by 54
Surveillance mechanism linking Bub1 loss to the p53 pathway
Gjoerup, O. V., Wu, J., Chandler-Militello, D., Williams, G. L., Zhao, J. J., Schaffhausen, B. S., Jat, P., & Roberts, T. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703164104 · Cited by 54
What dermoscopy tells us about nevogenesis
Zalaudek, I., Catricalà, C., Moscarella, E., & Argenziano, G. (2010) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2010.01141.x · Cited by 54
Rôle de la transition épithélio-mésenchymateuse au cours de la progression tumorale
Puisieux, A. (2009) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32376-3 · Cited by 53
Nelson, D. M., McBryan, T., Jeyapalan, J. C., Sedivy, J. M., & Adams, P. D. (2014) · AGE · doi:10.1007/s11357-014-9637-0 · Cited by 53
Role of EZH2 histone methyltrasferase in melanoma progression and metastasis
Mahmoud, F. A., Shields, B. D., Makhoul, I., Hutchins, L. F., Shalin, S. C., & Tackett, A. J. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1167291 · Cited by 53
Deciphering the RAS/ERK pathway in vivo
Dorard, C., Vucak, G., & Baccarini, M. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160135 · Cited by 53
Pathology and genomics of pediatric melanoma: A critical reexamination and new insights
Bahrami, A., & Barnhill, R. L. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26792 · Cited by 53
Oncogenic activation of PI3K induces progenitor cell differentiation to suppress epidermal growth
Ying, Z., Sandoval, M., & Beronja, S. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0218-9 · Cited by 53
Sale, M. J., Balmanno, K., Saxena, J., Ozono, E., Wojdyła, K., McIntyre, R. E., Gilley, R., Woroniuk, A., Howarth, K., Hughes, G. D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09438-w · Cited by 53
Cellular senescence in the tumor microenvironment and context‐specific cancer treatment strategies
Yasuda, T., Baba, H., & Ishimoto, T. (2021) · FEBS Journal · doi:10.1111/febs.16231 · Cited by 53
The complex interplay between aging and cancer
Trastus, L. A., & di Fagagna, F. D. (2025) · Nature Aging · doi:10.1038/s43587-025-00827-z · Cited by 56
Fluorescence-Based Detection and Quantification of Features of Cellular Senescence
Cho, S., & Hwang, E. S. (2011) · Methods in cell biology · doi:10.1016/b978-0-12-385493-3.00007-3 · Cited by 53
Senescence: the good the bad and the dysfunctional
Pazolli, E., & Stewart, S. A. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.12.002 · Cited by 52
Calcium homeostasis in cancer: A focus on senescence
Farfariello, V., Iamshanova, O., Germain, E., Fliniaux, I., & Prevarskaya, N. B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.03.005 · Cited by 52
Quantitative digital in situ senescence-associated β-galactosidase assay
Shlush, L. I., Itzkovitz, S., Cohen, A., Rutenberg, A., Berkovitz, R., Yehezkel, S., Shahar, H., Selig, S., & Skorecki, K. L. (2011) · BMC Cell Biology · doi:10.1186/1471-2121-12-16 · Cited by 52
Significance of Cellular Senescence in Aging and Cancer
Grimes, A., & Chandra, S. (2009) · Cancer Research and Treatment · doi:10.4143/crt.2009.41.4.187 · Cited by 52
Pawlikowski, J. S., Adams, P. D., & Nelson, D. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.109728 · Cited by 52
Lin, S., Yang, J., ELKAHLOUN, A. G., Bandyopadhyay, A. M., Wang, L., Cornell, J. E., Yeh, I., Agyin, J. K., Tomlinson, G. E., & Sun, L. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-10-0849 · Cited by 52
Cui, Y., Borysova, M. K., Johnson, J., & Guadagno, T. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1491 · Cited by 52
Evasion of Cell Senescence Leads to Medulloblastoma Progression
Tamayo-Orrego, L., Wu, C., Bouchard, N., Khedher, A., Swikert, S. M., Remke, M., Skowron, P., Taylor, M. D., & Charron, F. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.061 · Cited by 52
Komseli, E.-S., Pateras, I. S., Krejsgaard, T., Stawiski, K., Rizou, S. V., Polyzos, A., Roumelioti, F., Chiourea, M., Mourkioti, I., Paparouna, E., et al. (2018) · BMC Genomics · doi:10.1186/s12864-017-4375-1 · Cited by 52
Acquisition of Oxidative DNA Damage during Senescence
Martien, S., & Abbadie, C. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1404.010 · Cited by 52
New techniques in dermatopathology that help to diagnose and prognosticate melanoma
Carlson, J. A., Ross, J. S., & Slominski, A. T. (2008) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2008.09.007 · Cited by 52
Conway, C., Beswick, S., Elliott, F., Chang, Y., Randerson‐Moor, J. A., Harland, M., Affleck, P., Marsden, J., Sanders, D. S., Boon, A., et al. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20753 · Cited by 52
Kilbey, A., Blyth, K., Wotton, S., Terry, A., Jenkins, A., Bell, M., Hanlon, L., Cameron, E. R., & Neil, J. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3016 · Cited by 52
Senescence: an antiviral defense that is tumor suppressive?
Reddel, R. R. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp274 · Cited by 52
MicroRNAs, Long Non-Coding RNAs, and Circular RNAs in the Redox Control of Cell Senescence
Lettieri-Barbato, D., Aquilano, K., Punziano, C., Minopoli, G., & Faraonio, R. (2022) · Antioxidants · doi:10.3390/antiox11030480 · Cited by 51
Metadata
- Authors
- Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S.
- Affiliations
- The Netherlands Cancer Institute (NL)
- University of Michigan (US)
- Harold C. Simmons Comprehensive Cancer Center (US)
- Corresponding author
- Mooi, Wolter J.
- Peeper, Daniel S.
- Venue
- Nature
- Published
- 2005-08
- Volume
- 436
- Issue
- 7051
- Pages
- 720-724
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2150740687
- Semantic Scholar
- bfbf433cb25b4a5e054e35a6850376801a03b87d
- Cited by
- 2,160
- References
- 31
- Citations by year
- 2026: 35 · 2025: 43 · 2024: 70 · 2023: 82 · 2022: 77 · 2021: 85 · 2020: 86 · 2019: 108 · 2018: 99 · 2017: 91 · 2016: 121 · 2015: 112 · 2014: 120 · 2013: 143 · 2012: 136
- FWCI
- 66.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, BRAF V600E mutation, melanocytes, nevi, melanoma, cell cycle arrest, senescence-associated heterochromatin foci, SUV39H1, histone methyltransferase, p16INK4a, p53, PTEN, oncogene-induced senescence, tumor suppression
- MeSH terms
- beta-Galactosidase, Cell Cycle, Cell Line, Fibroblasts, Humans, Infant, Melanocytes, Nevus, Telomere, Cellular Senescence, In Situ Hybridization, Fluorescence, Cyclin-Dependent Kinase Inhibitor p16, Proto-Oncogene Proteins B-raf, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
